Manhattan Scientifics, Inc. (MHTX)
OTCMKTS: MHTX · Delayed Price · USD
0.0014
-0.0003 (-17.65%)
Apr 23, 2024, 11:33 AM EDT - Market closed

Company Description

Manhattan Scientifics, Inc., a technology incubator, engages in the development and commercialization of life-enhancing technologies in the United States.

It develops technologies in the areas of nano-technologies and nano-medicine. The company offers nanostructured bulk metals and alloys in the form of rod, bar, wire, and foil for medical implants and other applications.

The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York.

Manhattan Scientifics, Inc.
Country NY
Founded 1992
Industry Medical Devices
Sector Healthcare
Employees 1
CEO Emmanuel Tsoupanarias

Contact Details

Address:
244 Fifth Avenue, Suite 2341
New York, New York 10001
United States
Phone 212-726-2107
Website mhtx.com

Stock Details

Ticker Symbol MHTX
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001099132
CUSIP Number 563122100
ISIN Number US5631221000
Employer ID 85-0460639
SIC Code 3690

Key Executives

Name Position
Marvin Maslow Founder and Chairman of the Board
Emmanuel Tsoupanarias President, Chief Executive Officer and Director
Leonard C. Friedman Secretary
Robert Romeo Proulx President of Imagion

Latest SEC Filings

Date Type Title
Apr 10, 2024 8-K Current Report
Apr 2, 2024 10-K Annual Report
Apr 2, 2024 NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Nov 20, 2023 10-Q Quarterly Report
Nov 15, 2023 NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB
Aug 21, 2023 10-Q Quarterly Report
Aug 14, 2023 NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB
May 31, 2023 10-Q/A [Amend] Quarterly report
May 22, 2023 10-Q Quarterly Report
May 15, 2023 NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB